Eight Advisory supported Sanofi in its acquisition of Inhibrx

Eight Advisory supported Sanofi in its acquisition of Inhibrx

Eight Advisory provided financial due diligence services to Sanofi in support of its acquisition of Inhibrx, Inc. This transaction is in line with Sanofi's strategy to expand its portfolio to address unmet medical needs of patients.

Sanofi, an innovation-driven global healthcare company, provides life-changing therapeutic solutions for patients. The addition of the INBRX-101 asset for the treatment of alpha-1 antitrypsin deficiency, a disease that primarily affects the lungs and leads to progressive tissue degradation, underlines the Group’s strategy to develop distinctive products.

 

Inhibrx is a publicly traded clinical-stage biopharmaceutical company specialising in the development of a broad portfolio of new biologic drug candidates. The company utilises a variety of protein engineering methodologies to address the specific needs of complex targets and diseases, including its proprietary protein engineering platforms.

 

Under the terms of the merger agreement, Sanofi will acquire all outstanding shares of Inhibrx for $30.0 per share in cash, representing an equity value of approximately $1.7 billion (on a fully diluted basis).

 

We are pleased to have supported Sanofi in the financial due diligence review of this listed target company,” says Katia Wagner, Partner at Eight Advisory.

 

Eight Advisory team members supporting on this transaction :

Financial Due Diligence: Katia Wagner, Partner, Laurent Williot, Partner, Louis Legros, Director, and Guillaume Heral, Manager.

Katia

Wagner

Partner

Transaction Services

Eight Advisory Paris

Laurent

Williot

Partner

M&A Transaction Services, Energy & Infrastructure

Your message has been sent

Thank you, your application has been sent.

Report request

Similar
Articles

Deals

Eight Advisory supported Clearway Group in its acquisition of Secontec Group

4 Mar 2024

Read more

Deals

Eight Advisory supported Capza on its investment in Bnetwork 

4 Mar 2024

Read more

Articles

Defense Finance: addressing the defense technology financing challenges

4 Mar 2024

Read more

Deals

Eight Advisory supported Activa Capital on its investment in Go! Formations 

29 Feb 2024

Read more

Deals

Eight Advisory supported Strada Partners on its investment in Elsyca 

29 Feb 2024

Read more

All the news

Your message has been sent

Thank you, your application has been sent.

What is the subject of your request?

  • General questions
  • Jobs
  • Information for the press

Specify your request

Choose an office

  • Eight Advisory London

  • Eight Advisory Paris

  • Eight Advisory Rennes

  • Eight Advisory Nantes

  • Eight Advisory Lyon

  • Eight Advisory Marseille

  • Eight Advisory Brussels

  • Eight Advisory Frankfurt

  • Eight Advisory Munich

  • Eight Advisory Hamburg

  • Eight Advisory Zürich

  • Eight Advisory Amsterdam

  • Eight Advisory Köln

  • Eight Advisory Madrid

  • Eight Advisory New York

Application

Unsolicited application

Specify your request